This proof of concept study will evaluate the ability of a new, ultrasound based technology called Bullseye Constructive Shearwave Interference (CSI) (trade name, Bullseye Elasticity Quantification) to measure lymphedema of the upper arm among breast cancer survivors. The study's hypothesis is that the CSI device can detect the presence of clinically significant lymphedema when compared with the standard arm tape measurement.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
21
handheld ultrasound
Durham Regional Hospital
Durham, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Difference in mean shear wave speed across sites measured between lymphedema and non-lymphedema limbs
differences in shear wave speed (Bullseye) device measurements between lymphedema affected and non-affected contralateral limb
Time frame: baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.